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Background: The cadmium (Cd) present in air pollutants and cigarette smoke has the potential of causing multiple
adverse health outcomes involving damage to pulmonary and cardiovascular tissue. Injury to pulmonary epithelium
may include alterations in tight junction (TJ) integrity, resulting in impaired epithelial barrier function and enhanced
penetration of chemicals and biomolecules. Herein, we investigated mechanisms involved in the disruption of TJ
integrity by Cd exposure using an in vitro human air-liquid-interface (ALI) airway tissue model derived from normal
primary human bronchial epithelial cells.
Methods: ALI cultures were exposed to noncytotoxic doses of CdCl2 basolaterally and TJ integrity was measured
by Trans-Epithelial Electrical Resistance (TEER) and immunofluorescence staining with TJ markers. PCR array analysis
was used to identify genes involved with TJ collapse. To explore the involvement of kinase signaling pathways, cultures
were treated with CdCl2 in the presence of kinase inhibitors specific for cellular Src or Protein Kinase C (PKC).
Results: Noncytotoxic doses of CdCl2 resulted in the collapse of barrier function, as demonstrated by TEER
measurements and Zonula occludens-1 (ZO-1) and occludin staining. CdCl2 exposure altered the expression of
several groups of genes encoding proteins involved in TJ homeostasis. In particular, down-regulation of select
junction-interacting proteins suggested that a possible mechanism for Cd toxicity involves disruption of the
peripheral junctional complexes implicated in connecting membrane-bound TJ components to the actin cytoskeleton.
Inhibition of kinase signaling using inhibitors specific for cellular Src or PKC preserved the integrity of TJs, possibly by
preventing occludin tyrosine hyperphosphorylation, rather than reversing the down-regulation of the junction-
interacting proteins.
Conclusions: Our findings indicate that acute doses of Cd likely disrupt TJ integrity in human ALI airway cultures
both through occludin hyperphosphorylation via kinase activation and by direct disruption of the junction-interacting
complex.
Keywords: Cadmium, Airway air-liquid-interface (ALI) culture, Tight junction, Occludin phosphorylation, Intracellular
junctional interacting proteinsIntroduction
Cadmium (Cd) is a highly toxic heavy metal present in
environmental pollution and tobacco smoke [1]. For the
general population, cigarette smoke is a major source of
Cd exposure, with approximately 10-20% of the Cd in
mainstream smoke inhaled and 50% of the inhaled dose
absorbed via the respiratory system. Thus, smokers usu-
ally have significantly higher urine and blood Cd levels
than nonsmokers [2,3]. Repeated low doses of Cd, such* Correspondence: robert.heflich@fda.hhs.gov
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unless otherwise stated.as those from daily cigarette smoking, accumulate in
various organs, leading to pulmonary, cardiovascular,
and renal toxicity [4-6].
It is postulated that Cd disturbs tissue homeostasis via
multiple mechanisms, including inducing apoptosis and
oxidative stress, inhibiting DNA repair, promoting DNA
demethylation, interfering with essential metals, and dis-
rupting E-cadherin-mediated cell adhesion [6]. Recent
studies conducted in renal tubule epithelial cells, rat sem-
iniferous epithelial cells, and human lung epithelial cells
revealed that exposure to Cd also can disrupt intercellular
tight junctions (TJs) and that the modes of action for theis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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that pulmonary disease is a common outcome of Cd-
related exposures and that the human airway is exposed
to Cd through, e.g., cigarette smoke, airway epithelium
could be a major target for Cd-mediated TJ disruption.
Whether or not such toxicity occurs and the underlying
mechanism for this toxicity, therefore, warrants further
investigation.
The TJ is a highly dynamic molecular structure in-
volved in maintaining and regulating tissue permeability
and polarity [11]. The basic structure of TJs comprises a
network of transmembrane proteins and cytoplasmic
plaques connected by adaptor proteins [12]. Dysregula-
tion of TJ permeability has been implicated in a variety
of pathological conditions in pulmonary tissues, including
asthma and lung cancer [13]. Possible molecular targets
leading to TJ disruption have been studied extensively. In
addition to the well-understood membrane components
that are mainly involved in mediating intercellular adhe-
sion, the cytoplasmic fractions of the TJs increasingly have
been recognized for their essential roles in regulating TJ
biogenesis and transmitting cellular signals between differ-
ent components of the TJ plaques [12]. It is believed that
the expression of TJ-associated proteins as well as their
subcellular localization and phosphorylation status are
essential in maintaining the barrier function of TJs in
response to various stimuli, such as oxidative stress,
inflammation, and cytokines [14,15]. The function of
phosphorylation modification may involve both modu-
lating interactions between TJ-associated molecules and
signal transduction upon internal and external stimulation
[16,17]. Several protein kinases and phosphatases have
been identified that are directly involved in occludin phos-
phorylation on multiple residues [18].
Well-differentiated human airway air-liquid-interface
(ALI) tissue cultures derived from normal primary hu-
man bronchial epithelial (NHBE) cells develop mature
TJs and retain all major cell types found in human air-
way epithelium. Thus, they have emerged as an ad-
vanced in vitro tissue model that closely recapitulates
in vivo airway epithelial tissue architecture and func-
tion. In this study, we explored molecular events un-




CdCl2 was purchased from MP Biomedicals (CAS No.
10108-64-2; purity > 99.0%; Santa Ana, CA). Mouse and
rabbit anti-occludin antibodies and rabbit anti-ZO-1
antibody were purchased from Invitrogen (Grand Island,
NY). Mouse anti-VAP-33 antibody was obtained from
BD Biosciences (San Jose, CA). Rabbit anti-TJAP1 anti-
body was obtained from Abcam (Cambridge, MA). Mouseanti-GAPDH and rabbit anti-cingulin antibodies were
purchased from Sigma-Aldrich (St. Louis, MO). Mouse
anti-p-Tyr antibody PY99, c-Src kinase inhibitor I, and
pan Protein Kinase C (PKC) inhibitor (GF 109203X) were
purchased from Santa Cruz Biotechnology (Dallas, TX).
Mouse anti-p63 and rabbit anti-Ki-67 antibodies were ob-
tained from Thermo Scientific (Pittsburgh, PA) and Lab
Vision Corporation (Fremont, CA), respectively. Horse-
radish peroxidase-conjugated goat anti-mouse and goat
anti-rabbit antibodies were purchased from Vector La-
boratories (Burlingame, CA). Alexa Fluor®488 goat anti-
mouse IgG and Alexa Fluor®594 goat anti-rabbit IgG were
obtained from Invitrogen. IRDye 680RD goat anti-mouse
IgG, IRDye 680RD goat anti-rabbit IgG, and IRDye
800CW goat anti-mouse IgG secondary antibodies were
purchased from LI-COR (Lincoln, NE).
Airway epithelial ALI culture
NHBE cells cryopreserved at Passage 1 were purchased
from Lonza (Walkersville, MD). Cells were quickly thawed
at 37°C upon receipt and expanded on collagen-coated
P100 tissue culture dishes in bronchial epithelium growth
medium (BEGM, Lonza). ALI cultures were established
using a PneumaCult ALI medium kit and by following the
manufacturer’s instructions (STEMCELL Technologies,
Vancouver, Canada). Briefly, after the cells reached ap-
proximately 70% confluency in the P100 tissue culture
dishes, they were induced by incubation for 24 h in In-
duction Medium provided by the ALI medium kit. The in-
duced cells were collected with 0.025% Trypsin-EDTA,
resuspended in Expansion Medium provided by the me-
dium kit, and seeded onto 24-well collagen-coated PET
cell culture inserts (BD Biosciences, San Jose, CA). The
cells were incubated in Expansion Medium added to both
the apical and basolateral chambers of the culture inserts
until they reached 100% confluency. The apical medium
then was removed and the cells were fed basolaterally only
with kit-supplied serum- and bovine pituitary extract-free
Maintenance Medium. The basolateral medium was re-
placed every 2 or 3 days for approximately 4 weeks until
the cultures became fully differentiated.
Histology
ALI cultures were washed briefly with phosphate-buffered
saline (PBS, pH 7.4) and fixed in 10% neutral buffered for-
malin for 48 h. The membranes were excised from the
culture inserts with a surgical blade and embedded in par-
affin. Five-μm-thick tissue sections were cut, mounted on
slides, and deparaffinized by processing through a series
of xylene and ethanol solutions. Hematoxylin and eosin
(H&E) staining was conducted using a Leica Autostainer.
Deparaffinized tissue sections also were stained for p63,
Ki-67, and mucus-producing goblet cells. For p63 and
Ki-67 staining, antigens were retrieved by boiling the
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15 min (3 × 5 min/run) using a microwave oven. After
the slides were cooled to room temperature, they were
washed in dH2O for 5 min. The slides then were
treated with 3% hydrogen peroxide containing 1% so-
dium azide for 10 min to quench endogenous peroxi-
dases. Following blocking the nonspecific binding in
0.5% casein for 20 min, the slides were incubated for
1 h at room temperature with antibodies for p63 or Ki-67
diluted 1:100 and 1:200, respectively, in PBS containing
1% bovine serum albumin (BSA, Sigma-Aldrich). After
the conclusion of the primary antibody incubation, the
slides were incubated with the respective horseradish
peroxidase-conjugated secondary antibodies for 30 min
at room temperature. Staining was developed with diami-
nobenzidine (DAB, Sigma-Aldrich) substrate for 5 min at
room temperature. Sections then were counter-stained
with hematoxylin and mounted with Permount mounting
medium (Thermo Scientific). Mouse IgG, rabbit IgG, or
PBS was added in the place of primary antibodies to serve
as the negative staining controls.
Mucus-producing goblet cells were identified by peri-
odic acid Schiff ’s (PAS) staining. Slides with deparaf-
finized tissue sections were incubated in periodic acid
solution for 5 min at room temperature. The slides then
were washed with H2O and incubated in Schiff ’s reagent
for 30 min at room temperature. The slides were washed
again in running tap water and counter-stained with
hematoxylin.
Cd exposure conditions
Treatment medium containing various concentrations
of CdCl2 was prepared by diluting a stock solution in
Maintenance Medium. Exposure to CdCl2 was carried
out from the basolateral side of the ALI cultures to
mimic the systemic (blood) exposure of airway epithe-
lium to Cd. Four hundred μL treatment medium were
added to the basolateral compartments for 24, 48, or
72 h. After the treatment, the basolateral medium was
removed and both the apical and basolateral surfaces of
the cultures were washed with PBS once before pro-
ceeding to the following analyses.
Trans-epithelial electrical resistance (TEER)
TEER measurements were made using an Endohm-6 tis-
sue resistance chamber and an epithelial volt-ohmmeter
(EVOM2, World Precision Instruments, Sarasota, FL).
The EVOM2 was calibrated using a test electrode prior
to the measurement. The culture insert was positioned
in the center of the Endohm-6 chamber containing 1 mL
of the electrolyte solution (0.9% NaCl, 1.25 mM CaCl2,
10 mM HEPES); and 300 μL of the electrolyte solution
were added to the apical chamber of the culture insert.
TEER values were taken 3 times per data point and anaverage was calculated. An empty culture insert was
used to correct for the background resistance. Three
cultures were used for each treatment concentration
and time point.
Cell viability
Cell viability was measured using the CellTiter 96®
Aqueous Non-radioactive Cell Proliferation MTS Assay
(Promega, Madison, WI). The MTS assay is based on
the bio-reduction of a tetrazolium compound (MTS) to
a soluble formazan product by metabolically active cells.
The amount of formazan product formed is directly pro-
portional to the number of live cells, thus providing a
quantitative measure of cell viability. After TEER meas-
urement, 200 μL fresh Maintenance Medium containing
the MTS/PMS reagent were added to the apical com-
partment of the culture inserts and incubated for 1 h at
37°C to allow the metabolic conversion of tetrazolium to
formazan. One hundred and twenty μL of the apical
medium then were transferred to a clear 96-well plate.
The optical density of the apical medium was measured
at 490 nm using a Synergy H4 plate reader (BioTek,
Winooski, VT). Triplicate cultures were used for each
treatment concentration and time point.
Immunofluorescence
Double immunofluorescence labeling with Zonula oc-
cludens-1 (ZO-1) and occludin was conducted by fol-
lowing the method described previously [19]. Prior to
the treatment, the accumulated mucus was removed by
washing the apical side of the ALI cultures thoroughly
with PBS. The cultures then were treated for 24 h with
various concentrations of CdCl2 in the presence or ab-
sence of inhibitors of c-Src or PKC. At the end of the
treatment, the cultures were washed with PBS twice
and permeabilized in methanol for 30 min at −20°C.
After washing with PBS for 15 min (3 × 5 min/wash),
the cultures were incubated for 1 h with 100 μL of goat
anti-rabbit ZO-1 and goat anti-mouse occludin anti-
bodies (both diluted 1:500 in PBS containing 10% nor-
mal goat serum), followed by washing with PBS 3 times
(5 min/wash) to remove the unbound antibodies. One
hundred μL of Alexa Fluor® 488 goat anti-mouse IgG or
Alexa Fluor® 594 goat anti-rabbit IgG (both diluted
1:500 in PBS with 10% normal goat serum) were added
to the apical chamber and the cultures were incubated
in dye-conjugated secondary antibodies for 1 h in the
dark. The cultures were again washed 3 times with PBS
(5 min/wash) and post-fixed with freshly prepared 4%
paraformaldehyde for 30 min at room temperature in
the dark. The membranes were excised from the plastic
insert support using a surgical blade and mounted on a
positively charged microscope slide with 30 μL VECTA-
SHIELD® Mounting Medium containing 4’,6-diamidino-
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were captured with a Nikon fluorescence microscope
equipped with appropriate filters.
Human tight junction PCR array
Total RNA was isolated using an miRNeasy Mini Kit
(Qiagen, Gaithersburg, MD) by following the manu-
facturer’s instructions. The quality of the total RNA was
assessed using the Bio-Rad Experion Automated Electro-
phoresis System (Hercules, CA) and RNA samples with
an RNA Integrity Number ≥ 9.5 were used for cDNA
synthesis. Four hundred ng of the total RNA were used to
synthesize cDNAs using a Qiagen RT2 First Strand Kit.
Gene expression profiles were generated using human
TJ RT2 Profiler PCR arrays (SABiosciences, Gaithersburg,
MD) and a 7500 Fast Real-Time PCR System (Applied
Biosystems, Carlsbad, CA). The vehicle-treated control
was conducted in quadruplicate (N = 4) and each CdCl2
treatment was performed in triplicate (N = 3). Ct values
were normalized using the house-keeping gene, Hprt1,
prior to data analysis. Gene expression changes were cal-
culated using RT2 Profiler PCR Array Data Analysis v3.5
software (available on-line at: http://www.sabiosciences.-
com/pcrarraydataanalysis.php). Gene expression was com-
pared between the vehicle-treated control and the two
CdCl2 treatments using the ΔΔCt method. Student’s t-test
conducted on quadruplicate 2-ΔΔCt values for each gene in
the vehicle-treated control and on triplicate values for the
CdCl2-treated groups was used to assess the significance
of differences in gene expression. Genes with fold chan-
ges ≥ 1.5 and p-values ≤ 0.05 were selected as candidates
that respond to Cd exposure.
Principal component analysis (PCA) was conducted
using ArrayTrack (U.S. FDA/National Center for Toxi-
cological Research, Jefferson, AR). Briefly, PCR array data
corrected for backgrounds were imported into ArrayTrack
and normalized using Total Intensity Normalization. Ex-
pression ratios (treated/control) were log2-transformed.
The transformed data were used for PCA to evaluate the
effect of Cd exposure. Among the nine principal com-
ponents considered by the ArrayTrack software, the pro-
gram selected the first, second and third components as
the most informative; these accounted for 45.79, 31.70
and 10.12% of the variance in the correlation matrix,
respectively.
Immunoblotting
Total cell lysates were prepared using the Pierce M-PER
Mammalian Protein Extraction Reagent supplemented
with 1 × SIGMAFAST™ Protease Inhibitor Cocktail. Pro-
tein concentrations were determined using the BCA pro-
tein assay. Ten μg aliquots of total protein were loaded
onto a NuPage® Novex® 4-12% Bis-Tris gel (Invitrogen)
and proteins were separated in MES running buffer at200 V for 35 min. The separated proteins then were trans-
ferred to a nitrocellulose membrane at 30 V for 1 h and
blocked with Odyssey Blocking Buffer (LI-COR) for 1 h at
room temperature with gentle rocking. Subsequently, the
membrane was incubated overnight at 4°C with antibodies
diluted in Odyssey Blocking Buffer with 0.1% Tween-20.
Proteins were visualized with IRDye-conjugated secon-
dary antibodies and a LI-COR Odyssey CLx Imaging
System.
Co-immunoprecipitation
Co-immunoprecipitation (co-IP) was conducted using
the Pierce Co-IP kit according to the manufacturer’s in-
structions. Briefly, 40 μg of rabbit anti-occludin antibody
were immobilized with AminoLink Plus Coupling Resin
and stored at 4°C until the analysis. Cells were lysed in
100 μL IP Lysis/Wash Buffer supplemented with 1 ×
SIGMAFAST™ Protease Inhibitor Cocktail. Protein con-
centrations were determined using the BCA protein assay
and 500 μg of total protein were precleared through 40 μL
of Control Agarose Resin to minimize nonspecific protein
binding. Equal volumes of the precleared cell lysate were
added to the antibody-coupled resin and incubated over-
night at 4°C with gentle mixing. The protein complex was
eluted in 35 μL Elution Buffer and 20 μL of the elute were
analyzed for p-Tyr by immunoblotting.
Statistical analysis
All data are presented as mathematical mean values ±
standard error of the mean. Differences between the
vehicle-treated control and CdCl2-treated groups were
assessed by using one-way ANOVA followed by Dunnett’s
test provided by the SigmaPlot version 11 statistics pack-
age. Data were tested for normality. p-values ≤ 0.05 were
considered statistically significant.
Results
Morphological evaluation of the ALI tissue model
The morphology of differentiated ALI cultures was eval-
uated by histological methods 5 weeks after the initial
seeding onto the permeable membrane support. H&E
staining of the paraffin-embedded tissue sections indi-
cated that the ALI cultures were fully differentiated into
a pseudostratified mucociliary epithelium, with cells re-
sembling goblet cells interspersed among ciliated cells
along the apical side of the cultures (Figure 1A). Differ-
ent types of epithelial cells were further distinguished by
cell-specific markers. The cuboidal-shaped basal cells
were identified by staining with the progenitor cell mar-
ker, p63 (Figure 1B). Cells expressing p63 were found ex-
clusively along the basolateral side of the ALI culture.
Cells undergoing active proliferation also were located
only on the basolateral side, as demonstrated by staining
with the cellular proliferation marker, Ki-67 (Figure 1C).
Figure 1 Morphological characterization of ALI human airway cultures. ALI cultures were fixed in 10% formalin 5 weeks after the initial
seeding onto the permeable membrane support. Tissue sections were stained with H&E (A), p63 (B), Ki67 (C), and PAS (D). Examples of positively
stained cells are indicated by arrows. The arrows in (A), (B), (C), and (D) indicate ciliated cells, basal cells, actively proliferating cells, and goblet
cells, respectively.
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lipid components in mucin, was used to identify the
mucus-secreting goblet cells (Figure 1D). Consistent with
the H&E staining, PAS-positive goblet cells were distri-
buted along the apical side of the culture. Residual se-
creted mucus also was detected on the apical side by PAS
staining.CdCl2 reduces TEER values and induces cellular toxicity
TEER measurements were made on CdCl2-treated ALI
cultures, followed by the evaluation of cytotoxicity with the
MTS assay. Cultures were treated basolaterally with various
concentrations of CdCl2 for 24, 48, or 72 h as described in
the Methods section. CdCl2 caused dose- and time-
dependent decreases in TEER values. Treatment with
100 μM CdCl2 produced an approximate 50% reduction in
TEER following both the 24- and 48-h exposures
(Figure 2A), and increasing the treatment duration to 72 h
further decreased the TEER values close to background
levels (i.e., the resistance of an empty culture insert). Treat-
ments with 10 and 30 μM CdCl2 had only minor effects on
TEER values, whereas the integrity of the cultures wascompletely disrupted with a dose of 300 μM CdCl2 at all
sampling times.
The MTS assay revealed a trend in dose–response tox-
icity similar to that observed with the TEER measurements
(Figure 2B). Doses up to 100 μM CdCl2 did not significantly
decrease cell viability at any of the time points tested. A
dose of 300 μM, however, completely inhibited the meta-
bolic activities of the cultures at all sampling time points,
indicating that the cultures were no longer viable. The IC50
value for CdCl2 determined by the MTS assay fell between
100 μM and 300 μM, which was higher than that of
approximately 100 μM estimated by TEER measurements
after the 24-h treatment. Given that the 100 μM CdCl2 was
noncytotoxic and induced an approximately 50% reduction
in TEER measurement, we selected concentrations of 30,
50, and 100 μM for our subsequent mechanism studies.
Acute treatment with CdCl2 disrupts TJ integrity
The drop in TEER values indicated a possible disruption
of TJ function caused by CdCl2 treatment. Thus, alter-
ations in TJ integrity in response to CdCl2 exposures were
further investigated using immunofluorescence staining
of two TJ markers, ZO-1 and occludin. In vehicle-treated
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Figure 2 Evaluation of transepithelial electrical resistance (TEER) and cellular toxicity in CdCl2-treated human ALI cultures. Cultures were
treated from the basolateral side with various concentrations of CdCl2 for 24, 48, or 72 h. The cultures were washed briefly in PBS and TEER
measurements (A) were conducted before processing the cultures for cytotoxicity evaluation using the MTS assay (B). Data (N = 3) are presented
as means ± standard deviation. *p < 0.05 was considered to be significant compared to the vehicle-treated control.
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well-defined localization around cell borders, indicating
the presence of intact TJs (Figure 3, panels A and B).
The merged images of ZO-1 and occludin fluorescence
staining further revealed their colocalization at the TJs
(Figure 3, panel D). Treatments with 30 μM and 50 μM of
CdCl2 did not alter the TJ integrity and colocalization of
ZO-1 and occludin after 24 h (Figure 3, panels E and F
and panels I and J), an observation consistent with the
TEER measurement (Figure 2A). After the 24-h treatment
with 100 μM CdCl2, however, the staining of these two TJ
markers was not limited to cellular boundaries as ob-
served in vehicle-treated control group. Both ZO-1 and
occludin exhibited partial membrane delocalization and
redistribution to the cytoplasm (Figure 3, panels M and N).
It was noteworthy that CdCl2 only partially disrupted TJs
at 100 μM, as the colocalization of ZO-1 and occludin
at cellular boundaries was still visible in some areas of
the cultures.Acute treatment with CdCl2 modulates genes associated
with TJs
The human TJ RT2 Profiler PCR array was used to measure
the relative expression of 84 genes involved in TJ assembly
and regulation. Cultures were treated basolaterally with ve-
hicle, 30 μM and 100 μM CdCl2 for 24 h. The selection of
the doses was based upon the extent of TJ disruption elic-
ited by these doses inferred from the TEER measurements
and staining for ZO-1 and occludin.
Nineteen genes had average threshold cycles greater than
30 and thus were excluded from the subsequent analysis.
Principal component analysis (PCA) was performed to
investigate the relationships for gene expression among
the samples from the different dose groups (Figure 4). The
vehicle-treated control samples and the low dose samples
were loosely grouped together, indicating a minimum effect
on gene expression associated with the 30 μM CdCl2
treatment. Samples treated with 100 μM CdCl2 were more
tightly grouped together and separated from both the
Figure 3 Induction of TJ disruption by CdCl2. Cultures were treated from the basolateral side with 30, 50 and 100 μM CdCl2 for 24 h, and
immunofluorescence staining was performed with antibodies for ZO-1 and occludin. Merged images demonstrated the colocalization of ZO-1
and occludin on the cellular borders in vehicle-treated control and 30 μM- and 50 μM-treated groups. Note apparent condensation of staining of
ZO-1 and occludin in 100 μM CdCl2-treated cultures. Descriptions of the individual lettered panels are given in the text.
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component 1 was found to be a convenient parameter to
differentiate the treatment effects elicited by different doses
of CdCl2.
Using the criteria defined in our study, 3 genes were
modulated by 30 μM CdCl2 and 29 genes exhibited signifi-
cant changes in their expression ratios (treatment/control)
in response to the 100 μM CdCl2 treatment (Table 1).
Among the 29 genes that demonstrated marked changes
to 100 μM CdCl2, 11 genes were up-regulated and 18genes were down-regulated. Notably, claudin 2 displayed
differential responses to the 30 μM- and 100 μM-
treatments.
Genes that were differentially expressed are involved
in a wide range of TJ-related biological processes, in-
cluding cell surface receptors, the junction-interacting
complex, G protein signaling, and protein kinase signaling
(Figure 5). Nearly 40% of the genes differentially expressed
by 100 μM CdCl2 were involved with the functions of the
cytoplasmic junctional-protein complex. Cell surface
Blue: 0 µM CdCl2
Green: 30 µM CdCl2
Red: 100 µM CdCl2
Figure 4 3D depiction of principal component analysis (PCA) of gene expression in cultures treated with vehicle, 30 μM CdCl2, or
100 μM CdCl2. Sixty five genes that met the criteria defined by the RT
2 Profiler PCR Array Data Analysis v3.5 software from SABiosciences
were uploaded to the ArrayTrack program. The PCA is based on the log2 ratios and expression profiles across all the 65 genes in the PCR array.
The blue, green, and red dots indicate cultures treated with vehicle, 30 μM CdCl2, and 100 μM CdCl2, respectively. The first three principal
components are plotted. The captured variance of PC1 (first principal component), PC2 (second principal component; the label is not shown),
and PC3 (third principal component) were 45.79%, 31.70%, and 10.12%, respectively.
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among the top groups of genes that were significantly
modulated by Cd exposure.
Since genes involved in the junctional-protein complex
were among the top gene groups modulated by 100 μM
CdCl2, three differentially expressed junctional-interacting
genes, e.g., cingulin, tight junction interaction protein 1
(TJAP1), and VAP-33, were selected and changes in
their protein expression were further examined by im-
munoblotting. Cingulin and TJAP1 exhibited clear dose-
dependent decreases in their protein expression with
increasing concentrations of CdCl2; the expression of VAP-
33 also was decreased but its decrease was less dose-
responsive (Figure 6A). Quantitative assessment, however,
indicated that treatment with 100 μM CdCl2 decreased
the expression of all three junctional-interacting proteins
by approximately 50%, decreases that were statistically
significant (Figure 6B).
Inhibitors of c-Src and PKC preserve TJ integrity by
inhibiting occludin Tyr phosphorylation, rather than
reversing the down-regulation of junctional interacting
proteins
We postulated that kinase activation might be involved
in Cd-mediated TJ disruption. To test our hypothesis,
ALI cultures were treated with 100 μM CdCl2 in the
presence or absence of inhibitors of c-Src or PKC. The
biological consequences of kinase inhibition on TJ integ-
rity were examined by immunofluorescence staining of
ZO-1 and occludin. Treatment of ALI cultures with
either kinase inhibitor alone did not change the staining
patterns of ZO-1 and occludin, both of which were
localized on cellular borders (not shown) as observed in
vehicle-treated control cultures (Figure 7A, panels aand b). Consistent with our initial observations, 100 μM
CdCl2 partially disrupted TJ integrity (Figure 7A,
panels e through h). Concurrent treatment with CdCl2
and the kinase inhibitors, however, effectively preserved
the intact TJ structures, as demonstrated by the well-
defined staining for ZO-1 and occludin and their coloca-
lization along the cellular borders (Figure 7A, panels i
through p).
The effects of kinase inhibition on the protein expres-
sion of the select junctional-interacting proteins were
further explored by immunoblotting. Cotreatment with
either of the kinase inhibitors did not prevent the CdCl2-
induced down-regulation of these proteins (Figure 7B).
Approximate 50% decreases in the expression of cingulin
and VAP-33 (p < 0.05) were observed in all treated groups
compared to the control; while the expression of TJAP1
also was decreased in all treated groups, cotreatment with
CdCl2 and the PKC inhibitor failed to significantly down-
regulate its expression (Figure 7C).
Since the protective effect of the kinase inhibitors on
TJ disruption did not appear to involve the junctional-
interacting proteins, we postulated that Cd exposure
might alter the phosphorylation status of occludin on Tyr
residues, and consequently cause TJ collapse. Because of
the lack of an antibody specifically recognizing p-Tyr-
occludin, occludin was first enriched by immunopre-
cipitation of equal amounts of whole cell lysate and
Tyr-phosphorylated occludin was detected in the eluate
using an antibody raised against Tyr-phosphorylated
proteins. The level of total occludin was similar in all
treatment groups (Figure 7D, upper panel). Treatment
with CdCl2 increased occludin Tyr phosphorylation by
approximately 2.5-fold (Figure 7D, lower panel, lane 4 vs.
lane 1). Concurrent treatment with CdCl2 and inhibitors
Table 1 Significantly regulated TJ-related genes in response to CdCl2 treatment in human airway epithelial ALI
cultures (fold change ≥ 1.5, p value < 0.05)
Gene
name
Gene description Biological function Group 1 (30 μM) Group 2 (100 μM)
Fold change p value Fold change p value
Up-regulated
ICAM1 Intercellular adhesion molecule 1 Cell surface receptors 13.89 0.000114
CRB3 Crumbs homolog 3 (Drosophila) Cell surface receptors 3.95 0.000507
CLDN1 Claudin 1 Cell surface receptors 2.99 0.000232
CLDN4 Claudin 4 Cell surface receptors 2.57 0.012412
OCLN Occludin Cell surface receptors 2.53 0.000418
ARHGEF2 Rho/rac guanine nucleotide exchange factor 2 G Protein signaling 2.15 0.007405
CLDN2 Claudin 2 Cell surface receptors 2.14 0.045285
TJP1 Tight junction protein 1 (Zona occludens-1) Junction interacting proteins 2.13 0.00451
SMURF1 SMAD specific E3 ubiquitin protein ligase 1 Cytoskeleton Regulator/
G Protein Signaling
1.71 0.005857
CLDN12 Claudin 12 Cell surface receptors 1.65 0.008749
JAM3 Junctional adhesion molecule 3 Junction interacting proteins 1.62 0.015438
AMOTL1 Angiomotin like 1 Junction interacting proteins/
Cytoskeleton regulation
1.99 0.009748
HCLS1 Hematopoietic cell-specific Lyn substrate 1 Junction interacting proteins 1.62 0.017181
Down-regulated
MPDZ Multiple PDZ domain protein Junction interacting proteins −7.35 0.000001
PTEN Phosphatase and tensin homolog Protein kinase signaling −4.22 0
ICAM2 Intercellular adhesion molecule 2 Cell surface receptors −4.01 0.019093
CGN Cingulin Junction interacting proteins −3.74 0.007739
CDK4 Cyclin-dependent kinase 4 G Protein signaling −3.58 0.012422
CLDN16 Claudin 16 Cell surface receptors −3.15 0.000298
MAGI1 Membrane associated guanylate kinase, WW and




CLDN8 Claudin 8 Cell surface receptors −2.77 0.000306
CLDN2 Claudin 2 Cell surface receptors −1.96 0.03226
GNAI1 Guanine nucleotide binding protein (G protein),
alpha inhibiting activity polypeptide 1
G Protein signaling −2.70 0.000373
VAPA VAMP (vesicle-associated membrane protein)-
associated protein A, 33kDa
Junction interacting proteins −2.20 0.000723
TJAP1 Tight junction associated protein 1 (peripheral) Junction interacting proteins −2.20 0.028018
ASH1L Ash1 (absent, small, or homeotic)-like (Drosophila) Cytoskeleton Regulator −2.14 0.000877
SYMPK Symplekin Junction interacting proteins −2.07 0.040784
CSNK2A2 Casein kinase 2, alpha prime polypeptide Protein kinase signaling −1.97 0.004506
CSDA Cold shock domain protein A Junction interacting proteins/
Cytoskeleton regulator
−1.73 0.000039
MPP6 Membrane protein, palmitoylated 6 (MAGUK p55
subfamily member 6)
Protein kinase signaling −1.71 0.0007
MLLT4 Myeloid/lymphoid or mixed-lineage leukemia
(trithorax homolog, Drosophila); translocated to, 4
Junction interacting proteins −1.60 0.014185
CSNK2A1 Casein kinase 2, alpha 1 polypeptide Protein kinase signaling −1.55 0.002999
Cao et al. Respiratory Research  (2015) 16:30 Page 9 of 14for c-Src or PKC effectively prevented the increase in
occludin phosphorylation (Figure 7D, lower panel, lanes
2 and 3 vs. lane 4).Discussion
In this study, we investigated the effects of Cd on the in-
tegrity of TJs formed in an in vitro airway ALI tissue
Figure 5 Expression changes of TJ-related genes in cultures exposed basolaterally to 100 μM CdCl2. The means of the gene expression
changes are plotted. All genes presented here have a fold change≥ 1.5 and p-value < 0.05. N = 4 for vehicle-treated control group; N = 3 for
100 μM CdCl2-treated group.
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lected as a test compound because of its reported dis-
ruption of TJs formed by many cell types [7-10] and its
potential for airway exposure due to its presence in






































Figure 6 Cingulin, TJAP1, and VAP-33 protein expression changes in
basolateral side with various concentrations of CdCl2 for 24 h, and whole c
expression of cingulin, TJAP1, and VAP-33 was detected by immunoblottin
Density of the bands were quantified and statistically analyzed (N = 3). *Indcan occur by two routes, directly to the luminal (air
interface) side of the airway through exposure to Cd in
aerosols (e.g., cigarette smoke) or by systemic exposure
to Cd circulating in the blood. In our study we exposed











response to CdCl2 treatment. Cultures were treated from the
ell lysate was collected and separated by electrophoresis. The
g using specific antibodies. (A). Representative Western blots. (B).
icates p < 0.05 compared to the vehicle-treated control.
Figure 7 Protective effects of kinase inhibitors for c-Src and PKC on Cd-induced TJ disruption. (A). TJ integrity was assessed using
immunofluorescence staining of ZO-1 and occludin. Cotreatment of CdCl2 and kinase inhibitors prevented Cd-induced TJ disruption. Descriptions of
the individual lettered panels are given in the text. (B). Representative Western blots showing protein expression of cingulin, TJAP1, and VAP-33. Kinase
inhibitors failed to prevent the down-regulation of these junction-interacting proteins. (C). Density of the Western blots in Figure 7B. were quantified and
statistically analyzed (N= 3). *Indicates p < 0.05 compared to the vehicle treated control. (D). Tyr-phosphorylation of occludin was modulated by CdCl2.
Cultures were treated from the basolateral side with 100 μM CdCl2 in the presence or the absence of kinase inhibitors for c-Src or PKC. Tyrosine
phosphorylated occludin was detected in occludin-enriched immunoprecipitates. Both kinase inhibitors prevented Tyr hyperphosphorylation of occludin.
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ally relevant route of exposure (i.e., systemic exposure),
but also was done for a practical reason. Apical exposure
of ALI culture would ideally use an aerosol of the test
agent delivered in appropriately designed exposure cham-
bers. Exposure of ALI cultures to aqueous solutions of Cd
(e.g., dissolved in a small volume of PBS or H2O) from the
apical side is possible, albeit less of a mimic of in vivo re-
spiratory exposure. However, we found that the aqueous
vehicle temporarily affects TJ integrity. We observed that
a 24-h treatment at the air-liquid interface with only PBS
significantly decreased TEER values, an effect that was re-
versible several hours after removal of the PBS. Basolateral
exposure avoids this temporary and possibly confounding
factor that apparently results when the apical side of ALI
cultures is covered. Apical exposures, using appropriateexposure systems, would provide additional information
to inform a more complete accounting of Cd toxicity to
airway ALI cultures.
The results of our study confirmed that the structure of
the in vitro ALI cultures closely resembles the tissue archi-
tecture of in vivo airway epithelium. We further demon-
strated that noncytotoxic doses of CdCl2 (measured by the
MTS assay) compromised TJ barrier function likely via
two independent mechanisms, i.e., by up-regulating occlu-
din Tyr phosphorylation via kinase activation and by dir-
ectly disrupting the junctional-interacting complex crucial
for TJ biogenesis and signaling.
The reported blood levels of Cd in smokers [2] are
much lower than the doses of CdCl2 that produced sig-
nificant changes in TJ integrity in the ALI cultures. It
should be noted that the half-life of Cd is greater than
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macromolecules and accumulate in cells [2]. Therefore,
acute exposure of the ALI cultures may greatly under-
estimate the effects of chronic exposure to low doses of
Cd. We hypothesize that TJ disruption by more physio-
logically relevant concentrations of Cd may require lon-
ger treatment durations, allowing the accumulation of
Cd and manifestation of its toxic effects following repeated
exposures. Observations made from our acute-treatment
study provide insights into the possible mechanisms of Cd
toxicity; however, they cannot exclude the possibility that
TJ disruption occurs following longer treatment durations
with low doses of Cd. Although longer treatments were
not attempted in this study, one of the advantages of the
airway ALI tissue model is that it maintains its functional
and structural properties from weeks to months so that
longer term exposures conducted in such models are pos-
sible. Note also that the airway models used in our study
were prepared from cells derived from the large airways of
human lung tissue. ALI cultures also can be prepared
using primary cells from human small airway and alveolar
tissue and these should be investigated for TJ disruption
by Cd in future studies.
Human TJ PCR array and western blotting revealed
the dysregulation of the junctional-interacting complex-
associated proteins as a possible mechanism for Cd-
mediated TJ disruption. The junctional-interacting complex
is a multi-molecular structure located in the cytoplasm
and involved in bridging membranous TJ components
with the actin cytoskeleton. VAP-33 has been implicated
in the early recruitment of occludin to TJs and alteration
in its expression results in dislocation of occludin from
TJ patches [17]. Cingulin is found to connect TJ pro-
teins with actin cytoskeletons through its head sequence
and transmit signals during TJ biogenesis and regulation
[21-23]. TJAP1 is incorporated at late stages of TJ assem-
bly, and thus is postulated to have a possible role in stabil-
izing TJ plaques [24]. Considering their multiple functions
at various stages of TJ homeostasis, the Cd-induced dys-
regulation of the junctional interacting proteins observed
in our study could have taken place in a staged manner,
with down-regulation of VAP-33 occurring after TJAP1
and cingulin, resulting in several possible downstream ef-
fects, such as disassembly of the protein-junctional com-
plex, disruption of the actin cytoskeleton, dysregulation of
TJ signal transduction, and increased barrier permeability
due to redistribution of TJ proteins, eventually leading to
the collapse of TJs. In fact, previous reports have demon-
strated that Cd-mediated junction interruption is accom-
panied by disruption of the actin-based cytoskeleton in
other in vitro cell model systems [25,26]. Thus, our ob-
servations, in conjunction with these previous studies,
support a possible signaling cascade triggered during
Cd-induced TJ disruption involving dysregulation of boththe actin cytoskeleton and junctional-interacting proteins
that function as cytoskeletal adaptor proteins in pulmon-
ary airway epithelium.
Consistent with the report of Dokladney et al. [27],
our study also indicates that the protein expression of
occludin is not affected by Cd exposure, at least at the
concentrations tested. Rather, our observations suggest a
role for c-Src and PKC in Cd-mediated post-translational
modification of occludin in human airway epithelial ALI
cultures. Co-administration of c-Src or PKC inhibitors
prevented Cd-induced occludin Tyr hyperphosphoryla-
tion and the collapse of TJs, suggesting that kinase acti-
vation may be an early cellular event triggered by Cd
exposure. This effect of Cd on protein kinase activity is
not unprecedented; Cd induces conformational changes
and modulates the enzymatic activities of protein ki-
nases by either directly binding to their metal-binding
dicysteine-containing motifs or substituting for essential
metals, such as Zn2+, in their regulatory domains [28,29].
For kinases that are involved in TJ maintenance and re-
gulation, modulation of their activities by Cd may elicit a
cascade of related down-stream signaling, resulting in the
collapse of TJ integrity. For instance, occludin Tyr hyper-
phosphorylation by kinase activation may attenuate its
interaction with other TJ components, leading to its sub-
cellular dislocalization and ultimately, weakening of the TJ
structures. It is noteworthy that kinase signaling pathways
become dysregulated in several smoking-related pulmon-
ary diseases, such as in non-small cell lung cancer, asthma,
chronic obstructive pulmonary disease, and idiopathic
pulmonary fibrosis [30]. Thus, modulations of various kin-
ase activities by Cd in these disease settings warrant fur-
ther investigation.
Several protein kinases modulate TJ barrier functions
through occludin phosphorylation. c-Src directly binds
to the C-terminal domain of occludin, and Tyr residues
Y398/Y402 were identified as the c-Src phosphosites
[31,32]. Activation of c-Src by oxidative stress weakens
the barrier properties of Caco-2 cells, and is accompanied
by the redistribution of occludin and the TJ-associated
protein ZO-1 from cellular borders to the cytoplasm [33].
Other protein kinases, such as PKC, also are implicated in
phosphorylating occludin and modulating TJ permeability.
However, the exact role of the PKC family in occludin
phosphorylation and TJ regulation is less clear. Different
isoforms of PKCs may regulate TJ integrity by exerting
inhibitory or stimulatory effects on occludin phospho-
rylation in different cellular systems and under different
conditions [18]. Even though they mainly catalyze the
phosphorylation modifications on Thr and Ser residues,
the possible involvement of PKCs in Tyr phosphorylation
revealed by our study is consistent with a study conducted
on rat hippocampal slices demonstrating direct Tyr phos-
phorylation of the N-methyl-D-aspartate receptor by PKC
Cao et al. Respiratory Research  (2015) 16:30 Page 13 of 14activation [34]. Alternatively, it also is possible that Ser
and Thr phosphorylation of occludin by PKC activation
renders the Tyr residues more susceptible to phosphory-
lation by c-Src activation, thus suggesting an indirect in-
volvement of PKC in occludin Tyr phosphorylation in
response to Cd exposure.Conclusions
Our studies suggest a plausible mechanism for Cd tox-
icity in human airway ALI models. Given the protective
effect of kinase inhibitors on TJ integrity, kinase ac-
tivation is believed to be an early up-stream cellular
event triggered by Cd exposure. Furthermore, Tyr hyper-
phosphorylation of occludin by kinase activation could
potentially attenuate occludin interactions with other
junctional-interacting proteins and lead to its disloca-
tion from the cytoplasmic membrane. Based on the fact
that the kinase inhibitors did not reverse Cd-induced
down-regulation of the select junctional-interacting pro-
teins, we conclude that Cd disrupts TJ integrity through
at least two independent mechanisms. Besides causing
kinase activation and subsequently downstream occlu-
din Tyr hyperphosphorylation, Cd also may directly dis-
rupt the junction interacting complex by inhibiting gene
expression for junctional interacting proteins independent
of kinase signaling. The direct inhibition of junctional-
interacting protein genes may occur through binding of
Cd to the promoter region of their DNA. We hypothesize
that these combined effects alter the microenvironment of
TJ plaques and contribute to compromising the TJ barrier.
We, however, view our observations as a starting point for
understanding the toxicity of Cd in airway tissue. Further
studies should be conducted to explore the effects of ap-
ical exposure of the airway tissue models to aerosolized
Cd using systems that mimic in vivo exposures, and also
to evaluate the effects of chronic apical and basolateral
exposures to low doses of Cd. It also is possible that Cd
affects TJ integrity differently in different parts of the
airway, and studies similar to ours should be conducted
using ALI cultures prepared from small airway and al-
veolar cells.
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